首页精彩花絮热点报道专家介绍视频PPT专家访谈讨论区

2012BOA RANDOMIZED PHASE Ⅲ STUDY OF ERLOTINIB VERSUS OBSERVATION IN PATIENTS WITH NO EVIDENCE OF DIS